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Abstract
Background: In utero exposure to maternal viral infections is associated with a higher incidence of psychiatric disorders with 
a supposed neurodevelopmental origin, including schizophrenia. Hence, immune response factors exert a negative impact 
on brain maturation that predisposes the offspring to the emergence of pathological phenotypes later in life. Although 
ventral tegmental area dopamine neurons and their target regions play essential roles in the pathophysiology of psychoses, 
it remains to be fully elucidated how dopamine activity and functionality are disrupted in maternal immune activation 
models of schizophrenia.
Methods: Here, we used an immune-mediated neurodevelopmental disruption model based on prenatal administration of 
the polyriboinosinic-polyribocytidilic acid in rats, which mimics a viral infection and recapitulates behavioral abnormalities 
relevant to psychiatric disorders in the offspring. Extracellular dopamine levels were measured by brain microdialysis in both 
the nucleus accumbens shell and the medial prefrontal cortex, whereas dopamine neurons in ventral tegmental area were 
studied by in vivo electrophysiology.
Results: Polyriboinosinic-polyribocytidilic acid-treated animals, at adulthood, displayed deficits in sensorimotor gating, 
memory, and social interaction and increased baseline extracellular dopamine levels in the nucleus accumbens, but not in 
the prefrontal cortex. In polyriboinosinic-polyribocytidilic acid rats, dopamine neurons showed reduced spontaneously firing 
rate and population activity.
Conclusions: These results confirm that maternal immune activation severely impairs dopamine system and that the 
polyriboinosinic-polyribocytidilic acid model can be considered a proper animal model of a psychiatric condition that fulfills 
a multidimensional set of validity criteria predictive of a human pathology.
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Introduction
In the last decades, an association between in utero insults and 
enhanced risks for psychosis during adulthood has been under-
scored by both clinical and preclinical observations (Boksa, 
2010). In particular, among the vast number of environmental 
factors deemed responsible of prenatal insults, the exposure 
to maternal infections in utero, and specifically to maternal 
immune response products, has attracted special interest. In 
fact, epidemiological studies show increased risk for schizo-
phrenia and related disorders following prenatal maternal expo-
sure to infection or inflammation (Brown and Derkits, 2010). In 
line with this notion, several studies have demonstrated that 
by mimicking a viral or bacterial infection in pregnant dams at 
specific ages of pregnancy (mainly comparable with the second 
trimester of human pregnancy), the progeny displays a wide 
array of psychotic-like anatomical, behavioral, and neurochemi-
cal aberrations (Patterson, 2002; Meyer et  al., 2005; Patterson, 
2009; Boksa, 2010).
One of the most studied rodent models of neurodevelop-
mental psychosis induced by maternal infection is obtained by 
exposing fetuses to the administration to the mother of a pro-
inflammatory cytokine inductor, a double stranded RNA named 
polyriboinosinic-polyribocytidilic acid [poly(I:C)]), during gesta-
tional day (GD) 14 to 16 (Zuckerman et al., 2003). Poly(I:C) mimics 
the acute phase of viral infection by inducing a robust inflam-
matory response leading to the synthesis of several proinflam-
matory cytokines, such as interleukin-1β, interleukin-6, and 
tumor necrosis factor-α (Zuckerman et  al., 2003; Meyer et  al., 
2006). Interestingly, this particular type of prenatal immune acti-
vation elicits in rodent offspring a broad spectrum of behavioral 
impairments commonly described in schizophrenic patients, 
such as deficits in sensorimotor gating, latent inhibition, and 
social interaction (Zuckerman et al., 2003).
Furthermore, poly(I:C) rats show hypersensitivity to the 
effects of amphetamine and phencyclidine, compounds that 
are known to produce positive, negative, and cognitive schizo-
phrenia-like symptoms in healthy humans (Meyer et al., 2006; 
Ozawa et al., 2006). In addition, alongside of disrupted behavior, 
studies have also reported alterations in many neurotransmitter 
systems such as dopamine (Meyer et al., 2008; Vuillermot et al., 
2010), acetylcholine (Wu et al., 2015), and GABA (Richetto et al., 
2015).
In particular, dopaminergic abnormalities are considered a 
final common pathway in the neuropathogenesis of schizophre-
nia and remain central in both treatment and etiology (see Eyles 
et al., 2012 and references therein). Consistently, previous stud-
ies on maternal immune activation have found abnormalities in 
dopamine system in the offspring, such as increased numbers 
of tyrosine hydroxylase (TH) immunoreactive cells in the VTA 
and TH-positive terminals in the striatum (Meyer et  al., 2008; 
Winter et al., 2009; Vuillermot et al., 2010) or dopamine output in 
striatal slices (Zuckerman et al., 2003) in the lateral globus pal-
lidus and prefrontal cortex (Winter et al., 2009).
Although evidence is mounting that dopamine transmission 
is indeed impaired in several neurodevelopmental models of 
psychosis, including the poly(I:C) model, no study to our knowl-
edge has yet combined behavioral, neurochemical, and electro-
physiological analysis to assess and characterize this disruption.
To this aim, in the present study, we used the poly(I:C) 
neurodevelopmental model in rats. Male adult offspring were 
behaviorally assessed for deficits in sensorimotor gating, short-
term memory impairment, and social interaction. In these ani-
mals, mesolimbic dopamine neuron activity was examined by in 
vivo electrophysiology, and extracellular dopamine levels were 
measured by brain microdialysis.
Materials and Methods
Prenatal Treatment and Subjects
Female Sprague Dawley rats (Harlan, Italy) were mated at the 
age of 3  months, and the first day after the copulation was 
defined as GD 1.  We set our protocol basically following that 
already published by Zuckerman et al. (2003). At GD 15, preg-
nant dams were given either a single dose of poly(I:C) (4.0 mg/
kg, i.v.; InvivoGen, San Diego, CA) or an equivalent volume of 
endotoxin free saline solution in the lateral vein of the tail. To 
minimize the animal discomfort, we induced pregnant dams 
with isoflurane (2%) anesthesia, and then we kept the anes-
thesia during the whole injection with an infusion system. 
Pregnant dams were weighed for the first 3  days after the 
administration of either poly(I:C) or saline to evaluate weight 
loss as reported by previous investigations (Zuckerman et al., 
2003). Consistent with previous studies (Wolff and Bilkey, 2010), 
poly(I:C)-treated dams lost 2.6 ± 2.5 g (n = 11) 24 hours after the 
injection, whereas saline-treated dams increased their weight 
by 8.3 ± 2.1 g (n = 7). This difference is statistically significant 
(P < .01). The offspring were randomly assigned according to 
postnatal age to different experimental protocols (see Figure 1 
for a schematic description).
Adult (60–90 days) Sprague Dawley rats, offspring of poly(I:C)- 
or vehicle-treated dams, were bred in our facilities and were 
used for the experiments described below. We housed animals 
in groups of 3 to 6 in standard conditions of temperature and 
humidity under a 12-h-light/-dark cycle (with lights on at 7:00 
am) with food and water available ad libitum.
All experiments were approved by the University of Cagliari 
Committee on Animal Use and Care and performed in strict 
accordance with the EEC Council Directive of 24 November 1986 
(86/609). We made all efforts to minimize animal discomfort and 
to reduce the number of animals used.
Pregnant dams
poly (I:C) or vehicle
15 GD
Offspring
0 PND
Behavioral 
experiments
60-70 PND
Microdialysis
In vivo 
electrophysiology
70-90 PND
Figure 1. Schematic representation of the experimental protocol. Polyriboinosinic-polyribocytidilic acid [poly(I:C)] treatment during pregnancy consisted in a single i.v. 
injection of poly(I:C) (4 mg/kg) or vehicle (sterile pyrogen-free saline) at the 15th gestational day (GD). Behavioral experiments were performed between postnatal day 
(PND) 60 and 70, whereas in vivo electrophysiology and microdialysis between 70 and 90 PND.
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Behavioral Experiments
Prepulse Inhibition (PPI) of Startle Reflex
Startle and PPI were performed as previously described by Frau 
et  al. (2014) with slight modifications. The apparatus used for 
detection of startle reflexes (Med Associates, St Albans, VT) con-
sisted of 4 standard cages placed in sound-attenuated chambers 
with fan ventilation. Each cage consisted of a Plexiglas cylinder 
of 9-cm diameter mounted on a piezoelectric accelerometric 
platform connected to an analogue-digital converter. Two sepa-
rate speakers conveyed background noise and acoustic bursts, 
each one properly placed to produce a variation of sound within 
1 dB across the startle cage. Both speakers and startle cages were 
connected to a main PC, which detected and analyzed all cham-
ber variables with specific software. Before each testing session, 
acoustic stimuli and mechanical responses were calibrated via 
specific devices supplied by Med Associates.
On the testing day, each rat was placed in the cage for a 5-min-
ute acclimatization period consisting of 70-dB white noise back-
ground, which continued for the remainder of the session. Each 
session consisted of 3 consecutive sequences of trials (blocks). 
During the first and third blocks, rats were presented with only 
5 pulse-alone trials of 115 dB. In the second block was delivered 
a pseudorandom sequence of 50 trials, including 12 pulse-alone 
trials; 30 trials of pulse preceded by 74-, 78-, or 86-dB prepulses 
(10 for each level of prepulse loudness); and 8 no-stimulus tri-
als, where only the background noise was delivered. Inter-trial 
intervals were selected randomly between 10 and 15 seconds, 
while the inter-stimulus intervals were set at 100 milliseconds.
Novel Object Recognition (NOR) Test
NOR test was performed in adult rats (60–70 postnatal days 
[PND]) according to Spano et al. (2010). Each rat, after a habitua-
tion trial (10 minutes) on the arena (60 × 60 cm), was placed into 
the arena and allowed to explore 2 identical objects for 10 min-
utes (familiarization phase or T1). The second trial (choice phase 
or T2) started after an interval of 1 hour and lasted 3 minutes, 
with 2 objects placed in the same positions: one novel and the 
other a third copy of the object used in T1. The objects to be 
discriminated were made of glass, plastic, or metal, devoid of 
any natural significance, and were carefully cleaned with H2O2 
between each trial to avoid olfactory cues. Exploratory behavior 
was defined as the animal directing its nose toward the object 
at a distance ≤2 cm and/or touching it with the nose. Conversely, 
turning around, climbing over, or sitting on the object was not 
considered as exploratory behavior. The following parameters 
were examined: (1) total time spent exploring the objects during 
T1 and T2; (2) latency of first approaches, that is, time taken by 
animal to approach any of the 2 objects when it is placed into 
the experimental arena; and (3) frequency of approaches, that 
is, numbers of approaching the 2 objects. A  recognition index 
was calculated for each animal using the formula N/(N+F) × 100 
(N = time spent exploring the novel object; F = time spent explor-
ing the familiar one).
Social Interaction (SI) Test
SI test was performed in adult rats (60–70 PND) according to 
Spano et al. (2010). The experimental animal was placed into the 
arena (60 × 60 cm) with a novel unfamiliar conspecific rat of the 
same sex and of similar weight. Each test was performed with 
a novel rat that was exposed to neither the same test nor to 
any pharmacological treatment. Behavior was recorded for 10 
minutes, and time spent by the experimental rat in social inter-
actions (sniffing, following or grooming the partner, boxing, and 
wrestling) was monitored. The box was cleaned with H2O2 after 
each experimental session.
In Vivo Electrophysiological Experiments
Extracellular single unit recordings from VTA dopamine neurons 
in anesthetized male Sprague Dawley rats were carried out as 
described previously (Melis et al., 2008, 2009). We anesthetized 
animals (70–90 PND) with urethane (1.3 g/kg, i.p.), cannulated 
their femoral vein for i.v. administration of supplemental doses 
of the anesthetic, and placed them in the stereotaxic appara-
tus (Kopf, Tujunga, CA) with their body temperature maintained 
at 37 ± 1°C by a heating pad. The scalp was retracted and one 
burr hole was drilled above the parabrachial nucleus of the VTA 
(6.0 mm posterior from bregma, 0.3–0.6 mm lateral from midline) 
for the placement of a recording electrode. We localized struc-
tures according to the stereotaxic atlas of Paxinos and Watson 
(2007). Single unit activity of neurons located in the VTA (V 
7.0–8.0 mm from the cortical surface) was recorded extracellu-
larly with glass micropipettes filled with 2% pontamine sky blue 
dissolved in 0.5 M sodium acetate (impedance 2–5 MΩ). Single 
unit activity was filtered (bandpass 500–5000 Hz), and individ-
ual spikes were isolated by means of a window discriminator 
(Neurolog Instruments, Digitimer), displayed on a digital storage 
oscilloscope (TDS 3012, Tektronics), and digitally recorded. We 
sampled experiments on line and off line with Spike2 software 
(Cambridge Electronic Design, Cambridge, UK) by a computer 
connected to CED 1401 interface (Cambridge Electronic Design). 
The electrophysiological properties of spontaneously active 
VTA dopamine neurons were sampled by making 9 stereotaxic 
descents separated from each other by 200  µm, the sequence 
which was kept constant from animal to animal. Single units 
were identified according to already published criteria (Grace 
and Bunney, 1983; Ungless et al., 2004). We selected VTA dopa-
mine neurons when all criteria for identification were satisfied, 
including: firing rate ≤10 Hz, duration of action potential ≥2.5 ms, 
and inhibitory responses to hindpaw pinching. Each neuron 
was recorded for 2 to 3 minutes. Different electrophysiological 
parameters were evaluated, the first being the number of spon-
taneously active dopamine cells per electrode track (ie, popula-
tion activity). The other measurements were: (1) basal firing rate, 
(2) CV (SD of interspike intervals divided by the mean interspike 
interval; a measure of firing regularity), and (3) bursting activity. 
The onset of a burst was identified by 2 consecutive spikes with 
an interspike interval <80 milliseconds, and the termination 
of a burst was defined as an interspike interval exceeding 160 
milliseconds (Grace and Bunney, 1983). The degree and mode 
of bursting activity were measured by the percentage of spikes 
that occurred in bursts (percentage of spikes in burst), mean 
spikes per burst, and burst duration.
At the end of each recording section, negative DC (10 mA 
for 15 minutes) was passed through the recording electrode to 
eject Pontamine sky blue, which allowed the identification of the 
recorded cells. Brains were removed and fixed in 8% formalin 
solution. We identified the position of the electrodes microscop-
ically on serial sections (60 µm) stained with Neutral red.
Microdialysis Experiments
Extracellular dopamine levels were evaluated by microdialy-
sis in freely moving animals as previously described (Devoto 
et  al., 2015). Rats (70–90  days, 300–400 g) were anesthetized 
with Equithesin (0.97 g pentobarbital, 2.1 g MgSO4, 4.25 g chloral 
hydrate, 42.8 mL propylene glycol, 11.5 mL 90% ethanol, distilled 
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water up to 100 mL, 5 ml/kg, i.p.) and placed in a stereotaxic appa-
ratus (Kopf). Animals were implanted with vertical microdialysis 
probes (membrane AN 69-HF, Hospal-Dasco, Bologna, Italy; cut-
off 40 000 Dalton) in the shell of the nucleus accumbens (NAc; 
AP 1.8, L  ±  0.7, V -8.5 mm from bregma, 2 mm active membrane 
length) or in the medial prefrontal cortex (mPFC; AP 3.0, L  ±  0.6, 
V -6.5 mm from bregma, 4-mm active membrane length) accord-
ing to the coordinates of the atlas by Paxinos and Watson (1997).
The day after probe implantation, an artificial cerebrospi-
nal fluid (147 mM NaCl, 4 mM KCl, 1.5 mM CaCl2, 1 mM MgCl2, pH 
6–6.5) was pumped through the dialysis probes at a constant 
rate of 1.1 µL/min via a CMA/100 microinjection pump (Carnegie 
Medicine, Stockholm, Sweden). Samples were collected every 
20 minutes and dopamine and 3,4-Dihydroxyphenylacetic acid 
(DOPAC) simultaneously analyzed by HPLC with electrochemical 
detection. The HPLC systems were equipped with 3.0- x 150-mm 
C18 (3.5 µ) Symmetry columns (Waters, Milan, Italy) kept at 30°C 
by Series 1100 thermostats (Agilent Technologies, Waldbronn, 
Germany) and ESA Coulochem II detectors (Chelmsford, MA). 
The mobile phase consisted of 80 mM Na2HPO4, 0.27 mM EDTA, 
0.58 mM sodium octyl sulfate, 10% methanol, 4% acetonitrile, pH 
2.8 with H3PO4, delivered at 0.35 mL/min; the Coulochem analyti-
cal cell first electrode was set at +200 mV, the second at -300 mV. 
In these conditions, the detection limit (signal to noise ratio 3:1) 
was 0.3 pg of dopamine on column.
Basal extracellular values are expressed as pg/20 µL dialysate 
injected on column immediately after collection. Changes pro-
duced by drug treatments were calculated as percent of mean 
basal value obtained from 3 consecutive samples with a vari-
ance not exceeding 10%.
At the end of experiment, rats were killed by decapitation, 
and the brain was frozen and dissected with a cryostat for visual 
inspection of dialysis probe position.
Statistical Analysis
Startle response was based on the first positive wave that meets 
the minimum wave criteria and determined as mean startle 
amplitude of the pulse-alone trials relative to second block. 
Startle habituation across the 2 halves of the second block was 
evaluated as percent inter-block ratio using the following for-
mula: (mean startle amplitude for first half of the second block/
mean startle amplitude for second half of the second block) 
× 100. Latency to startle was based on the first peak value across 
pulse-alone trials of the second block. “Arbitrary units” were 
calculated by the Med Associates apparatus software by pro-
portionally converting the analog voltage signal recorded by the 
startle sensor (ranging from -10 to +10 V) to a digital unit, within 
a range of values between –2048 and +2048. The % PPI was cal-
culated only on the values relative to the second block using the 
following formula: ([mean startle amplitude pulse alone trials-
mean startle amplitude prepulse + pulse trials]/mean startle 
amplitude for pulse alone trials) × 100.
According to normality and homoscedasticity assumptions 
verified by Kolmogorov-Smirnov and Bartlett’s tests, data were 
compared across groups by Student’s t test (startle param-
eters) and 2-way ANOVA for repeated measures (PPI values). 
Significance threshold was set at 0.05.
For the NOR test, the time spent in exploring objects during 
T1 was calculated by summating the time spent exploring each 
identical object to produce a single score. For the SI test, the 
amount of time spent sniffing, following the partner, wrestling/
boxing, or grooming were summated for each rat to produce a 
single score. The unpaired Student’s t test was used to compare 
differences between experimental groups. In all tests statistical 
significance was set at P < .05.
For electrophysiological and microdialysis studies, averaged 
data from different experiments are presented as mean ± SEM. 
Statistical significance was assessed using 1- or 2-way ANOVA 
for repeated measures followed by either Dunnett’s or t test 
where appropriate.
Results
The Offspring of poly(I:C)-Treated Dams Display 
Abnormal PPI, NOR, and SI
To validate our model, we first carried out behavioral experi-
ments in poly(I:C) rats and controls at adulthood (PND 60–70). 
The acoustic startle response was measured at PND 60 to 70. As 
shown in Figure  2A-C, poly(I:C) treatment did not affect over-
all startle reflex values. Accordingly, no significant effects for 
mean startle amplitude (t(36) = 0.64, n = 15–23, P = .52, Student’s 
t test) (Figure  2A), latency to peak (t(36) = 0.49, n = 15–23, P = .62, 
Student’s t test) (Figure  2B), and startle habituation (t(36) = 0.35, 
n = 15–23, P = .72, Student’s t test) (Figure  2C) between control 
and poly(I:C) groups were found. Subsequently, a 2-way ANOVA 
(with treatment as independent factor and prepulse levels as 
repeated measures) assessed that the maternal infection with 
poly(I:C) significantly reduced PPI (main effect of treatment: 
F(1, 108) = 14.92, P < .001; main effect of prepulse level: F(2, 108) = 12.99, 
P < .001; interaction treatment × prepulse level: F(2, 108) = 2.1, P = .12, 
NS) (Figure 2D).
Next, we explored the presence of memory deficits and social 
withdrawal by means of the NOR test and SI test, respectively. 
During the familiarization phase (ie, T1), no difference was 
observed in the time of interaction with the objects between 
poly(I:C) and control rats (time of interaction with left and 
right objects: controls: 24.5 ± 6.0 and 25 ± 5.9 seconds; poly(I:C) 
42.3 ± 16.3 and 44.8 ± 17.7; n = 6, P > .05, Student’s t test). During 
the choice phase (ie, T2), the poly(I:C) offspring exhibited a sig-
nificantly lower preference for the novel object than control ani-
mals, as indicated by the ratio between the time spent with the 
novel and the familiar object, respectively (controls: 70 ± 5.6% 
and poly(I:C) 42.4 ± 3.65%, t(10) = 4.129, P < .01, n = 6) (Figure  2E). 
Thus, the poly(I:C) offspring expressed abnormally low sensi-
tivity to a novel object, which is indicative of poor short-term 
memory.
A separate group of animals, poly(I:C) and controls, under-
went the SI test. Poly(I:C)-exposed animals displayed a reduced 
time of interaction with the conspecific rats compared with 
controls (129.7 ± 7.3 vs 231 ± 25.4 seconds, n = 7, t(12) = 3.83, P < .01, 
Student’s t test) (Figure 2F), while no differences were found in 
the number of contact (data not shown).
Taken together, these results suggest that maternal immune 
activation induces several behavioral alterations in the offspring 
that have been associated with schizophrenia-like symptoms 
in humans and support previous literature on the validity of 
poly(I:C) administration during pregnancy as a model for schizo-
phrenia and related psychoses.
The Offspring of poly(I:C)-Treated Mothers Display 
Elevated Levels of Dopamine in the Shell of the NAc 
but Not in the mPFC
As dopamine imbalances are a hallmark of schizophrenia, we 
assessed whether offspring of poly(I:C)-treated dams display 
changes in baseline dopamine levels measured in the shell 
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of the NAc and in the mPFC by brain microdialysis in behav-
ing animals. For experiments in the NAc, 14 control and 18 
poly(I:C) rats were used. Basal values (mean ± SEM, expressed 
as pg/20 µL dialysate) are shown in Figure 3A. According to the 
hypothesis of enhanced dopamine transmission in poly(I:C) ani-
mals, extracellular dopamine levels were significantly higher 
in poly(I:C)- vs controls (+79%, t(22.49) = 2.536, P = .0186, Student’s 
t test with Welch’s correction) (Figure  3A). No difference was 
found in DOPAC concentration (controls = 1627 ± 236, n = 9, 
Poly(I:C) = 2015 ± 274 pg/20 µL, n = 12, t(19) = 1.0.72, P = .297, Student’s 
t test with Welch’s correction; data not shown).
 To test the functionality of D2 dopamine receptors in con-
trolling extracellular dopamine, we administered the selective 
D2 agonist quinpirole. Quinpirole (0.2 mg/kg, s.c.) decreased 
extracellular dopamine levels to about 40% of baseline level 
in both control and poly(I:C) rats (Figure 3C). Two-way ANOVA 
revealed a significant effect of time (F(5, 45) = 20.27; P < .0001) but 
no effect of treatment (F(1, 9) = 0.08199; P = .7811) or time x treat-
ment interaction (F(5, 45) = 0.3689; P = .8672). The functionality of 
dopamine transporter (DAT) was tested by local perfusion of 
cocaine (100 μM) into the NAc through the microdialysis probe. 
Cocaine perfusion increased extracellular dopamine levels to a 
maximum of about 1500% in both groups. Again, ANOVA analy-
sis yielded a significant value for time (F(5, 95) = 29.57; P < .0001) but 
no effect for treatment (F(1, 19) = 0.1234; P = .7292) or time x treat-
ment interaction (F(5, 95) = 0.2001; P = .9617). However, following 
cocaine perfusion, extracellular dopamine levels expressed 
as absolute values were significantly higher in poly(I:C) rats 
compared with controls (controls: 60.2 ± 13.8 pg/sample, n = 9; 
poly(I:C) = 117.50 ± 23 pg/sample, n = 12; effect of poly(I:C) treat-
ment: F(1, 19) = 12.98, P < .01, 2-way ANOVA). Experiments in the 
mPFC did not show differences in baseline dopamine and 
DOPAC levels between poly(I:C) and controls. For these experi-
ments, 11 controls and 12 poly(I:C) rats were used. Basal val-
ues are shown in Figure 3B. Dopamine levels did not differ in 
poly(I:C)- vs controls (Student’s t test with Welch’s correction, 
t(21) = 1.237, P = .22) (Figure 3B). No difference was found in DOPAC 
concentration (controls = 115.4 ± 15.5, poly(I:C) = 123.7 ± 12.7 
pg/20 µL, n, t(21) = 0.4174, P = .68, Student’s t test with Welch’s cor-
rection; data not shown).
Effect of Prenatal poly(I:C) on Dopamine Cell Activity 
and Functionality in Vivo
The increase in extracellular dopamine in the shell of the NAc 
prompted us to study dopamine cell activity in the VTA. To 
address this question, a population sampling of dopamine cells 
was performed in the parabrachial nucleus of the VTA (Figure 4A). 
Although the VTA shows a degree of heterogeneity, the subregion 
where we recorded from contains the largest density of dopamine 
neurons projecting to the NAc compared with the more medial 
levels of the posterior VTA (Yamaguchi et al., 2011; Lammel et al., 
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Figure 2. Behavioral abnormalities in polyriboinosinic-polyribocytidilic acid [poly(I:C)] offspring. Effects of poly(I:C) on startle reflex (A-C) and prepulse inhibition (PPI) 
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***P < .001 vs rats treated with vehicle (main effect of treatment). Prepulses are indicated by the intensity corresponding to decibels above background noise. AU, arbi-
trary units; %IBR, percent inter-block ratio; ms, milliseconds. For further details, see text. (E) Graphs show that offspring of poly(I:C)-treated mothers exhibited reduced 
discrimination index toward a novel object and (F) reduced social interactions. Data are expressed as means ± SEM. *P < .01 vs rats treated with vehicle (CTRL group).
 by guest on M
arch 23, 2016
http://ijnp.oxfordjournals.org/
D
ow
nloaded from
 
6 | International Journal of Neuropsychopharmacology, 2016
2015). A total of 257 dopamine cells was recorded from urethane 
anesthetized adult rats, 109 from rats exposed to poly(I:C) (n = 19), 
and 148 from controls (n = 14). Baseline activity of each cell was 
recorded for 120 to 180 seconds (Figure 4B).
Poly(I:C) rats showed a reduced number of spontaneously 
active VTA dopamine neurons compared with controls as meas-
ured by the analysis of cells per track (1.27 ± 0.13 vs 0.75 ± 0.11 
control vs poly(I:C); t(31) = 3.12, P < .01; Student’s t test) (Figure 4C).
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Figure  3. Enhanced extracellular dopamine (DA) levels in the nucleus accumbens (NAc) shell of polyriboinosinic-polyribocytidilic acid [poly(I:C)]-treated rats and 
effects of quinpirole and cocaine. Extracellular dopamine concentrations in the NAc shell (A) and medial prefrontal cortex (mPFC) (B) of control (CTRL) and poly(I:C) rats. 
(C) These graphs show the effect of systemically administered quinpirole (QUIN, 0.2 mg/kg, s.c., n = 5–6) on extracellular dopamine levels in the NAc shell expressed as 
percent of baseline (left) or in absolute values (pg/sample, right). (D) Locally perfused cocaine (COC, 100 µM, n = 9–12) enhances extracellular dopamine levels in the NAc 
shell. Data are expressed as percent of baseline (left) or in absolute values (pg/sample, right). The arrow represents the time of quinpirole administration, whereas the 
solid line represents the time of cocaine perfusion. Values are the mean ± SEM and are expressed as pg/20 µL dialysate. *P < .05, unpaired t test with Welch’s correction.
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In line with previous results in urethane-anesthetized rats 
(Kelland et  al., 1990; Lecca et  al., 2012), dopamine neurons 
recorded from control rats fired at 3.4 ± 0.15 Hz (n = 148) with a 
mean CV of interspike intervals of 64.1 ± 2.8% and presented 
16.38 ± 1.67% of spikes in bursts. On the other hand, as depicted 
in Figure 4D, putative dopamine neurons (n = 109) recorded from 
poly(I:C) rats exhibited a lower discharge activity (2.73  ± 0.18 Hz; 
t(255) = 2.874, P < .01; Student’s t test) than controls.
We carried out a more detailed analysis of burst episodes, 
which included parameters as the mean spikes per burst and 
mean burst duration. Poly(I:C) showed significant differences 
in the percentage of spikes in burst compared with controls 
(16.38 ± 1.67% vs 12.21 ± 1.79%; controls vs poly(I:C); t(255) = 1.68, 
P < .05; Student’s t test) (Figure 4E). Additionally, values of mean 
spikes per burst and mean burst duration (n = 84) of VTA dopa-
mine neurons were significantly altered compared with those 
Figure 4. Prenatal polyriboinosinic-polyribocytidilic acid [poly(I:C)] treatment dysregulates dopamine neuron firing activity in adulthood. (A) Example of a recording 
location for a ventral tegmental area (VTA) dopamine neuron in a poly(I:C)-treated rat (the triangle indicates the pontamine sky blue dye). The diagrams at right show 
samples of localizations of recording sites in poly(I:C) rats (black dots) and controls (white dots) as verified by histological sections. IP, interpeduncular nucleus; RN, red 
nucleus; SNr, substantia nigra pars reticulata. Scale bar  =  0.5 mm. (B) This panel shows traces illustrating representative extracellular recordings of a putative dopa-
mine neuron in the VTA of anesthetized rats belonging to the control group (CTRL, above) and poly(I:C) group (below). Dopamine neurons recorded from poly(I:C) rats 
typically show slower firing activity and a reduced bursting compared with CTRL. The left trace shows the typical broad spike waveform of a dopamine neuron. (C) The 
bar graph shows the number of spontaneously active VTA dopamine neurons, which was different between the experimental groups. The scatter plot in (D) displays 
individual dopamine neuron firing rate in CTRL and poly(I:C) rats. The horizontal lines represent average values that are significantly different between the 2 groups. 
Graph histograms represent the percentage of spikes in bursts (E), the mean number of spikes per each burst (F), and the mean burst duration (G). Data are expressed 
as percentage or mean ± SEM. *P < .05, **P < .01.
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recorded from vehicle-injected littermates (n = 126). In poly(I:C)-
treated rats, burst episodes were shorter (duration: 128.8 ± 8.64 
milliseconds vs 100.9 ± 7.77 milliseconds; controls vs poly(I:C); 
t(208) = 2.26, P < .05, Student’s t test) (Figure 4G) and included fewer 
spikes on average (spikes per burst: 2.76  ± 0.09 vs 2.52 ± 0. 08; con-
trols vs Poly(I:C); t(208) = 1.90, P < .05, Student’s t test) (Figure 4F).
Discussion
Our study, the first to combine electrophysiological and micro-
dialysis experiments on the dopamine system in a maternal 
immune activation model of schizophrenia, reveals that poly(I:C) 
treatment during pregnancy induces a disruption in dopamine 
functions in the offspring. Specifically, we found increased basal 
levels of dopamine in the NAc but, surprisingly, a reduction in 
both the number and the firing rate of spontaneously active 
dopamine cells in the VTA. As expected, electrophysiologi-
cal and neurochemical changes were paralleled by behavioral 
abnormalities, as revealed by deficits in PPI, SI, and NOR tests.
One of the hallmarks of positive symptoms of schizophrenia 
and related psychoses is an increased dopamine transmission in 
the mesolimbic system (Abi-Dargham et  al., 2000). Accordingly, 
we found increased baseline levels of dopamine in the NAc, but 
not in the mPFC, in poly(I:C)-treated rats compared with controls. 
This finding is in agreement with previous studies showing that 
poly(I:C) animals exhibited hyperactivity of the dopamine system 
(Zuckerman et al., 2003; Hadar et al., 2015). In addition, it has been 
reported that poly(I:C) treatment increases the number of TH 
immunoreactive cells in the VTA and TH-positive terminals in the 
striatum (Meyer et al., 2008; Winter et al., 2009; Vuillermot et al., 
2010). Other studies found increases in evoked striatal dopamine 
release ex vivo (Zuckerman et al., 2003) as well as augmented lev-
els of dopamine and DOPAC in the lateral globus pallidus and PFC 
(Winter et al., 2009) or only DOPAC in the striatum (Ozawa et al., 
2006). Conversely, our electrophysiological sampling of dopamine 
neurons in the VTA yielded a reduced number of spontaneously 
active cells together with a reduced firing activity. This finding 
is in contrast with previous studies that utilized the mitotoxin 
methyl azoxymethanol acetate (MAM) model of schizophrenia 
(Lodge and Grace, 2007; Du and Grace, 2013). The reason for this 
discrepancy might be due to the profound differences in the neu-
ropathological mechanisms between the 2 animal models [MAM 
vs poly(I:C)]. Administration of MAM, a DNA chelating agent, to 
pregnant dams at GD 15 or earlier disrupts normal fetal brain 
development and induces gross neurodevelopmental abnormali-
ties both in the macro- and microstructure, particularly in cor-
tical regions, and microcephaly (Singh, 1980; Jongen-Relo et al., 
2004). When MAM is administered at a later stage during preg-
nancy (GD 17), less severe abnormalities with hyperdopaminergia 
were reported (Lodge and Grace, 2007; Du and Grace, 2013). On 
the other hand, maternal immune activation models recapitulate 
the effects of a maternal viral infection by activating microglia 
and cytokines production. These effects induce severe functional 
changes but are believed to induce minor anatomical abnormali-
ties in the brain of offspring (Meyer, 2014).
A decrease in spontaneously active dopamine neurons, and 
in their frequency of discharge, is apparently difficult to reconcile 
with an augmented dopamine output in terminal regions, but it 
confirms previous reports that firing rate and release might not 
always be correlated (Manta et al., 2013) and that dopamine release 
can be controlled efficiently at terminal regions without increased 
impulse activity of dopamine cells. We tested the hypothesis 
that a reduced dopamine cell activity is an adaptation to aug-
mented synaptic dopamine, likely paralleled by a dysregulation in 
dopamine D2 autoreceptor sensitivity, as these receptors are key 
in determining the amount of released dopamine (Anzalone et al., 
2012). However, our microdialysis experiments indicated that D2 
receptor sensitivity did not change between poly(I:C) and controls, 
as quinpirole was equally effective in decreasing extracellular 
dopamine. We also tested the possibility that baseline increase in 
NAc dopamine was due to a deficient clearance of this neurotrans-
mitter from the synaptic cleft. Hence, a study with lipopolysac-
charide as a maternal immune activator showed reduced binding 
levels for the DAT in the NAc of the offspring of treated dams 
(Baharnoori et al., 2013). When cocaine was administered locally 
via the microdialysis fiber, dopamine levels were further markedly 
enhanced in poly(I:C) rats. This finding indicates that the effects of 
cocaine are not occluded and that dopamine clearance by DAT is 
similarly efficient in both groups of animals. However, this further 
increase in dopamine in spite of high baseline levels provides an 
explanation for the enhanced motor stimulating effect of amphet-
amine in poly(I:C) animals observed in other studies (Zuckerman 
et al., 2003; Ozawa et al., 2006).
Synchronized, neural network activity in the neocortex, 
termed cortical oscillations, has been known to impact the pat-
tern of neuronal firing of dopamine neurons (Gao et al., 2007), and 
this functional coupling allows a bidirectional control of dopamine 
neurons by the mPFC. Cortical oscillations and neural synchrony 
are abnormal in patients with schizophrenia and in animal mod-
els of this disease (Uhlhaas and Singer, 2010; Dickerson and Bilkey, 
2013; Gonzalez-Burgos et al., 2015). The disruption of dopamine 
neuron function could be due to a different cortical state result-
ing from poly(I:C) exposure. In fact, maternal immune activation 
has been shown to disrupt oscillatory activity in the hippocampus 
and the neocortex (Dickerson et al., 2010; Ducharme et al., 2012, 
2014; Dickerson and Bilkey, 2013). Irrespective of the mechanism 
involved, firing rate of dopamine neurons might be reduced or 
suppressed through an inhibitory synaptic feedback loop arising 
from the NAc (Paladini et al., 2003; Watabe-Uchida et al., 2012).
Consistent with previous studies, adult poly(I:C) offspring exhib-
ited significant PPI deficits. PPI provides an operational measure of 
sensorimotor gating, a neurophysiological mechanism that filters 
or “gates out” relevant stimuli from its surroundings, allowing the 
brain to focus attention on the most salient aspects of a stimulus 
(Braff and Geyer, 1990). The value of this experimental measure is 
based on its face, predictive, construct validity for schizophrenia 
and other psychiatric disorders (Wolff and Bilkey, 2008). In fact, 
PPI is regulated by the same forebrain regions involved in schizo-
phrenia, patients with schizophrenia show PPI dysfunctions, and 
PPI deficits are efficiently reversed by the benchmark antipsychot-
ics (Braff et al., 2001). Nevertheless, PPI alterations have not con-
stantly been reported in MIA model, and even some recent studies 
reported no PPI disruptions by poly(I:C) administration (Fortier 
et al., 2007; Van den Eynde et al., 2014). While the reasons for these 
apparent discrepancies remain unknown, they may reflect subtle 
differences in the timing of prenatal infections, the rat strain used, 
and the setting of the PPI protocol.
Unlike PPI parameters, poly(I:C) exposure failed to induce 
significant changes in startle reflex. Indeed, although our proto-
col is not specifically designed for assessing startle parameters, 
poly(I:C) offspring did not display significant differences in the 
average of startle reflex as well as in the startle habituation and 
latency. Of note, since PPI is extrapolated by startle values and PPI 
deficits occurred without concomitant alterations in the startle 
parameters, the reductions of PPI observed in poly(I:C) offspring 
likely reflect an effective impairment of sensorimotor gating.
One question that arises from our findings and other studies 
is whether maternal immune activation models schizophrenia or 
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other neurodevelopmental disorders, such as autism spectrum 
disorders. In fact, several epidemiological studies have demon-
strated an association between infection or inflammation during 
pregnancy and increased risk of autism (Atladottir et al., 2010). 
Prenatal infection and notably prenatal poly(I:C) and influenza 
virus administration can cause autism-relevant behaviors in the 
offspring and have been considered models of autism (Patterson, 
2009; Schwartzer et al., 2013). This is not surprising when con-
sidering the similarities between schizophrenia and autism-
related disorders, which might also share a neuroinflammatory 
pathogenesis during early fetal development (Meyer et al., 2011). 
Indeed, psychoses, ranging from autism to schizophrenia and 
bipolar disorders, might represent a continuum in both human 
pathology and animal models of these diseases.
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